193 related articles for article (PubMed ID: 10463288)
1. Primary malignant epithelial tumors of the liver in children: a study of DNA content and oncogene expression.
Zerbini MC; Sredni ST; Grier H; Cristofani LM; Latorre MR; Hollister KA; Alves VA; Weinberg DS; Perez-Atayde AR
Pediatr Dev Pathol; 1998; 1(4):270-80. PubMed ID: 10463288
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric analysis of the nuclear DNA content of hepatoblastoma.
Hata Y; Ishizu H; Ohmori K; Hamada H; Sasaki F; Uchino J; Inoue K; Naitoh H; Fujita M; Kobayashi T
Cancer; 1991 Dec; 68(12):2566-70. PubMed ID: 1657362
[TBL] [Abstract][Full Text] [Related]
3. Hepatoblastoma: DNA nuclear content, proliferative indices, and pathology.
Rugge M; Sonego F; Pollice L; Perilongo G; Guido M; Basso G; Ninfo V; Pennelli N; Gambini C; Guglielmi M; Fabiano A; Leandro G; Keeling JW
Liver; 1998 Apr; 18(2):128-33. PubMed ID: 9588772
[TBL] [Abstract][Full Text] [Related]
4. Apoptotic protein expression, glycogen content, DNA ploidy and cell proliferation in hepatoblastoma subtyping and their role in prognostication.
Chopra A; Iyer VK; Agarwala S; Mathur SR; Aron M; Gupta SD; Verma K
Pediatr Surg Int; 2010 Dec; 26(12):1173-8. PubMed ID: 20803149
[TBL] [Abstract][Full Text] [Related]
5. DNA analysis in hepatoblastoma by flow and image cytometry.
Schmidt D; Wischmeyer P; Leuschner I; Sprenger E; Langenau E; von Schweinitz D; Harms D
Cancer; 1993 Nov; 72(10):2914-9. PubMed ID: 8221557
[TBL] [Abstract][Full Text] [Related]
6. Tissue microarray immunohistochemical profiles of p53 and pRB in hepatocellular carcinoma and hepatoblastoma.
Azlin AH; Looi LM; Cheah PL
Asian Pac J Cancer Prev; 2014; 15(9):3959-63. PubMed ID: 24935581
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of DNA ploidy and c-erbB-2 oncoprotein overexpression in adenocarcinoma of Barrett's esophagus.
Nakamura T; Nekarda H; Hoelscher AH; Bollschweiler E; Harbeck N; Becker K; Siewert JR; Harbec N [corrected to Harbeck N]
Cancer; 1994 Apr; 73(7):1785-94. PubMed ID: 7907940
[TBL] [Abstract][Full Text] [Related]
8. Comparative image cytometric DNA ploidy of liver cell dysplasia and hepatocellular carcinoma.
Rubin EM; DeRose PB; Cohen C
Mod Pathol; 1994 Aug; 7(6):677-80. PubMed ID: 7991527
[TBL] [Abstract][Full Text] [Related]
9. [DNA ploidy pattern, p53 immunohistochemical overexpression and PCNA labeling index in "single nodular" human hepatocellular carcinomas from the viewpoint of biological malignant potential].
Saiki I; Une Y; Uchino J
Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():103-9. PubMed ID: 7611770
[TBL] [Abstract][Full Text] [Related]
10. Correlation between ploidy status, Erb-B2 and p53 immunohistochemical expression in primary breast carcinoma.
Midulla C; Giovagnoli MR; Valli C; Vecchione A
Anal Quant Cytol Histol; 1995 Jun; 17(3):157-62. PubMed ID: 7546049
[TBL] [Abstract][Full Text] [Related]
11. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
12. Analysis of genetic alterations associated with DNA diploidy, aneuploidy and multiploidy in gastric cancers.
Sugai T; Habano W; Jiao YF; Suzuki M; Takagane A; Nakamura S
Oncology; 2005; 68(4-6):548-57. PubMed ID: 16037688
[TBL] [Abstract][Full Text] [Related]
13. Lack of intratumoral heterogeneity in DNA ploidy pattern of hepatocellular carcinoma.
Nagasue N; Kohno H; Hayashi T; Yamanoi A; Uchida M; Takemoto Y; Makino Y; Ono T; Hayashi J; Nakamura T
Gastroenterology; 1993 Nov; 105(5):1449-54. PubMed ID: 8224647
[TBL] [Abstract][Full Text] [Related]
14. Prognostic influence of clinicopathologic features, DNA-ploidy, CD44H and p53 expression in a large series of resected hepatocellular carcinoma in France.
Terris B; Laurent-Puig P; Belghitti J; Degott C; Hénin D; Fléjou JF
Int J Cancer; 1997 Dec; 74(6):614-9. PubMed ID: 9421358
[TBL] [Abstract][Full Text] [Related]
15. Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases.
Blom R; Guerrieri C; Stâl O; Malmström H; Simonsen E
Gynecol Oncol; 1998 Jan; 68(1):54-61. PubMed ID: 9454661
[TBL] [Abstract][Full Text] [Related]
16. P53 protein expression and DNA ploidy in common epithelial tumors of the ovary.
Ioakim-Liossi A; Karakitsos P; Aroni K; Delivelioti K; Fotiou V; Fotiou S; Kyrkou K
Acta Cytol; 1997; 41(6):1714-8. PubMed ID: 9390130
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric analysis of DNA ploidy in hepatocellular carcinoma.
Ng IO; Lai EC; Ho JC; Cheung LK; Ng MM; So MK
Am J Clin Pathol; 1994 Jul; 102(1):80-6. PubMed ID: 8037171
[TBL] [Abstract][Full Text] [Related]
18. Tumor-cell DNA content predicts outcome in children and adolescents with clinical group III embryonal rhabdomyosarcoma. The Intergroup Rhabdomyosarcoma Study Committee of the Children's Cancer Group and the Pediatric Oncology Group.
Pappo AS; Crist WM; Kuttesch J; Rowe S; Ashmun RA; Maurer HM; Newton WA; Asmar L; Luo X; Shapiro DN
J Clin Oncol; 1993 Oct; 11(10):1901-5. PubMed ID: 8410116
[TBL] [Abstract][Full Text] [Related]
19. DNA ploidy study of resected hepatocellular carcinoma in cirrhotic liver.
Balsells J; Caragol I; Allende E; Diaz I; Charco R; Lazaro JL; Murio E; Margarit C
J Hepatol; 1996 Dec; 25(6):854-8. PubMed ID: 9007713
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric DNA analysis of cirrhotic liver cells in patients with hepatocellular carcinoma can provide a new prognostic factor.
Ruà S; Comino A; Fruttero A; Torchio P; Bouzari H; Taraglio S; Torchio B; Capussotti L
Cancer; 1996 Sep; 78(6):1195-202. PubMed ID: 8826940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
